IDEXX Laboratories Company Profile (NASDAQ:IDXX)

About IDEXX Laboratories

IDEXX Laboratories logoIDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company's segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IDXX
  • CUSIP: 45168D10
Key Metrics:
  • Previous Close: $142.23
  • 50 Day Moving Average: $127.37
  • 200 Day Moving Average: $116.39
  • 52-Week Range: $70.08 - $143.47
  • Trailing P/E Ratio: 58.29
  • Foreward P/E Ratio: 41.96
  • P/E Growth: 3.24
  • Market Cap: $12.70B
  • Outstanding Shares: 89,293,000
  • Beta: 0.48
Profitability:
  • Net Margins: 12.51%
  • Return on Equity: -671.57%
  • Return on Assets: 15.17%
Debt:
  • Debt-to-Equity Ratio: -5.48%
  • Current Ratio: 0.90%
  • Quick Ratio: 0.74%
Additional Links:
Companies Related to IDEXX Laboratories:

Analyst Ratings

Consensus Ratings for IDEXX Laboratories (NASDAQ:IDXX) (?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $118.33 (16.80% downside)

Analysts' Ratings History for IDEXX Laboratories (NASDAQ:IDXX)
Show:
DateFirmActionRatingPrice TargetDetails
2/14/2017Canaccord GenuitySet Price TargetBuy$145.00View Rating Details
2/3/2017Feltl & Co.DowngradeHold -> SellView Rating Details
9/29/2016Bank of America CorpReiterated RatingNeutralView Rating Details
8/16/2016Stifel NicolausBoost Price TargetBuy$120.00 -> $125.00View Rating Details
8/3/2016Northcoast ResearchUpgradeSell -> NeutralView Rating Details
4/13/2016Credit Suisse GroupBoost Price TargetOutperform$80.00 -> $85.00View Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
2/1/2016Piper Jaffray CompaniesReiterated RatingNeutral$73.00 -> $75.00View Rating Details
1/31/2016William BlairReiterated RatingOutperformView Rating Details
8/28/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for IDEXX Laboratories (NASDAQ:IDXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017        
2/2/2017Q416$0.51$0.58$436.07 million$443.00 millionViewListenView Earnings Details
11/1/2016Q316$0.60$0.62$448.60 million$448.30 millionViewListenView Earnings Details
8/2/2016Q216$0.62$0.74$444.83 million$467.00 millionViewListenView Earnings Details
4/29/2016Q116$0.47$0.51$403.48 million$417.55 millionViewListenView Earnings Details
1/29/2016Q415$0.44$0.48$397.39 million$400.00 millionViewListenView Earnings Details
10/28/2015Q315$0.53$0.54$409.33 million$406.00 millionViewListenView Earnings Details
7/30/2015Q215$0.57$0.60$412.57 million$413.30 millionViewListenView Earnings Details
4/28/2015Q115$0.99$0.98$394.38 million$382.00 millionViewN/AView Earnings Details
1/30/2015Q414$0.80$0.54$373.20 million$352.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.90$1.05$371.80 million$384.00 millionViewListenView Earnings Details
7/25/2014Q214$1.05$1.10$385.20 million$390.00 millionViewN/AView Earnings Details
4/25/2014Q114$0.87$0.89$361.58 million$360.20 millionViewListenView Earnings Details
2/4/2014Q413$0.81$0.82$347.08 million$354.10 millionViewN/AView Earnings Details
10/22/2013Q313$0.83$0.86$339.70 million$338.30 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.97$0.99$356.80 million$352.60 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.83$0.81$341.06 million$332.10 millionViewN/AView Earnings Details
1/29/2013Q4 2012$0.71$0.78$325.10 million$319.50 millionViewN/AView Earnings Details
10/19/2012$0.73$0.76ViewN/AView Earnings Details
7/20/2012$0.90$0.91ViewN/AView Earnings Details
4/20/2012$0.71$0.72ViewN/AView Earnings Details
1/27/2012$0.63$0.67ViewN/AView Earnings Details
10/21/2011$0.65$0.66ViewN/AView Earnings Details
7/22/2011$0.72$0.83ViewN/AView Earnings Details
4/21/2011$0.59$0.62ViewN/AView Earnings Details
1/28/2011$0.55$0.62ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IDEXX Laboratories (NASDAQ:IDXX)
Current Year EPS Consensus Estimate: $2.94 EPS
Next Year EPS Consensus Estimate: $3.39 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.46$0.47$0.47
Q2 20163$0.62$0.63$0.63
Q3 20163$0.58$0.62$0.60
Q4 20163$0.49$0.51$0.50
Q1 20173$0.59$0.61$0.60
Q2 20173$0.84$0.89$0.87
Q3 20173$0.75$0.76$0.75
Q4 20173$0.59$0.67$0.64
(Data provided by Zacks Investment Research)

Dividends

Dividend History for IDEXX Laboratories (NASDAQ:IDXX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for IDEXX Laboratories (NASDAQ:IDXX)
Insider Ownership Percentage: 2.79%
Institutional Ownership Percentage: 91.42%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/8/2017Brian P MckeonVPSell9,924$141.64$1,405,635.36View SEC Filing  
2/8/2017Daniel M JuniusDirectorSell3,000$141.75$425,250.00View SEC Filing  
2/8/2017Jonathan W. AyersChairmanSell36,250$141.63$5,134,087.50View SEC Filing  
11/29/2016Jonathan W AyersChairmanSell27,424$119.77$3,284,572.48View SEC Filing  
11/28/2016Jonathan W AyersCEOSell13,188$119.57$1,576,889.16View SEC Filing  
11/23/2016Thomas CraigDirectorSell8,500$120.06$1,020,510.00View SEC Filing  
11/9/2016Jonathan W. AyersChairmanSell40,000$107.85$4,314,000.00View SEC Filing  
11/8/2016William T EndDirectorSell5,000$109.87$549,350.00View SEC Filing  
8/25/2016Rebecca M HendersonDirectorSell9,924$110.43$1,095,907.32View SEC Filing  
8/15/2016Barry C JohnsonDirectorSell9,924$111.37$1,105,235.88View SEC Filing  
8/8/2016Michael J. Phd WilliamsInsiderSell49,560$108.94$5,399,066.40View SEC Filing  
8/5/2016William T EndDirectorSell5,000$108.50$542,500.00View SEC Filing  
8/4/2016Jonathan W. AyersChairmanSell60,000$107.69$6,461,400.00View SEC Filing  
5/5/2016William T EndDirectorSell4,924$85.87$422,823.88View SEC Filing  
2/24/2016Michael J Phd WilliamsEVPSell2,000$71.93$143,860.00View SEC Filing  
2/9/2016Thomas CraigDirectorSell2,054$69.52$142,794.08View SEC Filing  
2/8/2016Brian P. MckeonCFOSell9,054$69.65$630,611.10View SEC Filing  
11/30/2015Thomas CraigDirectorSell7,000$70.28$491,960.00View SEC Filing  
11/12/2015Rebecca M. HendersonDirectorSell2,300$68.39$157,297.00View SEC Filing  
8/31/2015Thomas CraigDirectorSell800$71.77$57,416.00View SEC Filing  
8/18/2015Michael J. Phd WilliamsEVPSell6,586$78.34$515,947.24View SEC Filing  
8/18/2015Thomas CraigDirectorSell2,900$79.41$230,289.00View SEC Filing  
8/17/2015Jonathan W AyersCEOSell14,799$78.45$1,160,981.55View SEC Filing  
5/18/2015William T EndDirectorSell3,527$134.51$474,416.77View SEC Filing  
3/10/2015William T EndDirectorSell3,500$150.89$528,115.00View SEC Filing  
3/4/2015Johnny D PowersEVPSell6,168$158.49$977,566.32View SEC Filing  
2/17/2015Brian P MckeonCFOSell5,000$156.99$784,950.00View SEC Filing  
2/12/2015Jonathan W AyersCEOSell58,245$155.45$9,054,185.25View SEC Filing  
2/5/2015Rebecca M HendersonDirectorSell2,934$156.27$458,496.18View SEC Filing  
2/4/2015Thomas CraigDirectorSell2,200$157.02$345,444.00View SEC Filing  
1/14/2015Jonathan W AyersCEOSell28,512$157.68$4,495,772.16View SEC Filing  
12/3/2014Jonathan W AyersCEOSell29,000$148.49$4,306,210.00View SEC Filing  
11/13/2014Thomas CraigDirectorSell5,000$152.45$762,250.00View SEC Filing  
11/5/2014Jonathan W AyersCEOSell29,000$143.45$4,160,050.00View SEC Filing  
11/4/2014Johnny D PowersEVPSell1,292$142.70$184,368.40View SEC Filing  
8/13/2014M Anne SzostakDirectorBuy2,000$127.03$254,060.00View SEC Filing  
2/20/2014M Anne SzostakDirectorBuy2,000$126.71$253,420.00View SEC Filing  
2/19/2014Thomas CraigDirectorSell4,800$125.42$602,016.00View SEC Filing  
2/3/2014Jonathan AyersCEOSell81,294$112.46$9,142,323.24View SEC Filing  
11/26/2013Jonathan AyersCEOSell78,178$105.29$8,231,361.62View SEC Filing  
11/22/2013Sophie VandebroekDirectorBuy1,000$107.84$107,840.00View SEC Filing  
11/13/2013Jonathan AyersCEOSell78,178$106.36$8,315,012.08View SEC Filing  
11/4/2013M Anne SzostakDirectorBuy1,000$108.24$108,240.00View SEC Filing  
11/4/2013Michael Phd WilliamsEVPSell6,020$108.19$651,303.80View SEC Filing  
10/31/2013William T EndDirectorSell2,500$108.32$270,800.00View SEC Filing  
10/25/2013Jonathan W AyersCEOSell78,178$104.36$8,158,656.08View SEC Filing  
9/13/2013Johnny PowersEVPSell13,128$96.59$1,268,033.52View SEC Filing  
9/5/2013Michael J Phd WilliamsEVPSell5,162$95.58$493,383.96View SEC Filing  
5/9/2013Ali NaquiVPSell12,961$87.00$1,127,607.00View SEC Filing  
2/4/2013Merilee RainesCFOSell175,929$94.25$16,581,308.25View SEC Filing  
11/13/2012Jonathan W AyersCEOSell15,000$89.92$1,348,800.00View SEC Filing  
9/5/2012Johnny D PowersEVPSell4,000$97.12$388,480.00View SEC Filing  
8/8/2012Merilee RainesCFOSell7,726$88.84$686,377.84View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for IDEXX Laboratories (NASDAQ:IDXX)
DateHeadline
News IconWatching Stock Levels for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Rives Journal (NASDAQ:IDXX)
rivesjournal.com - February 17 at 5:33 PM
biz.yahoo.com logoIDEXX LABORATORIES INC /DE Files SEC form 10-K, Annual Report (NASDAQ:IDXX)
biz.yahoo.com - February 17 at 5:33 PM
biz.yahoo.com logoIDEXX LABORATORIES INC /DE Files SEC form 8-K/A, Change in Directors or Principal Officers (NASDAQ:IDXX)
biz.yahoo.com - February 16 at 9:45 PM
News IconMarket Review: Focusing on These Shares: IDEXX Laboratories Inc. (IDXX) - Rives Journal (NASDAQ:IDXX)
rivesjournal.com - February 15 at 8:58 PM
News IconIs The Sell-Side Predicting That IDEXX Laboratories, Inc. (NASDAQ:IDXX) Will Move Higher? - Winfield Review (NASDAQ:IDXX)
winfieldreview.com - February 15 at 8:58 PM
realistinvestor.com logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Mean Rating At $2.5 - RealistInvestor.com (NASDAQ:IDXX)
www.realistinvestor.com - February 13 at 11:52 PM
News IconShares of IDEXX Laboratories, Inc. (IDXX) Sees Large Inflow of Net Money Flow - Highland Mirror (NASDAQ:IDXX)
www.highlandmirror.com - February 13 at 11:52 PM
finance.yahoo.com logoCan the Rally in IDEXX Laboratories (IDXX) Shares Continue? (NASDAQ:IDXX)
finance.yahoo.com - February 10 at 6:36 PM
nasdaq.com logoLooking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX) - Nasdaq (NASDAQ:IDXX)
www.nasdaq.com - February 10 at 4:47 AM
finance.yahoo.com logoLooking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX) (NASDAQ:IDXX)
finance.yahoo.com - February 9 at 6:46 PM
News IconTop Gainers of the Day: IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances (NASDAQ:IDXX)
twincountynews.com - February 7 at 7:08 PM
capitalcube.com logoIDEXX Laboratories, Inc. :IDXX-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017 (NASDAQ:IDXX)
www.capitalcube.com - February 7 at 7:08 PM
realistinvestor.com logoResearch Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) Price Target at $124.5 - RealistInvestor.com (NASDAQ:IDXX)
www.realistinvestor.com - February 6 at 5:56 PM
capitalcube.com logoIDEXX Laboratories, Inc. :IDXX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017 (NASDAQ:IDXX)
www.capitalcube.com - February 6 at 5:56 PM
News IconStrong Fourth Quarter for IDEXX Laboratories, Inc. | Fox Business - Fox Business (NASDAQ:IDXX)
www.foxbusiness.com - February 4 at 5:52 PM
rttnews.com logoIDEXX Laboratories Inc. (IDXX) Soared To A New High On Strong Q4 Earnings (NASDAQ:IDXX)
www.rttnews.com - February 3 at 6:25 PM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances – Todays Top Gains (NASDAQ:IDXX)
twincountynews.com - February 3 at 6:25 PM
us.rd.yahoo.com logoIDEXX Labs downgraded by Feltl & Co. (NASDAQ:IDXX)
us.rd.yahoo.com - February 3 at 6:25 PM
fool.com logoStrong Fourth Quarter for IDEXX Laboratories, Inc. (NASDAQ:IDXX)
www.fool.com - February 3 at 3:45 PM
News IconIDEXX Laboratories (IDXX) Releases Earnings Results, Beats Expectations By $0.07 EPS (NASDAQ:IDXX)
xboxonezone.com - February 3 at 4:36 AM
nasdaq.com logoIDEXX Laboratories Inc. (IDXX) Has Climbed To A New High On Strong Q4 Results (NASDAQ:IDXX)
www.nasdaq.com - February 3 at 4:36 AM
seekingalpha.com logoIDEXX Laboratories (IDXX) Q4 2016 Results - Earnings Call Transcript (NASDAQ:IDXX)
seekingalpha.com - February 3 at 4:36 AM
nasdaq.com logoIDEXX Laboratories (IDXX) Q4 Earnings Rise; Tweaks View - Nasdaq (NASDAQ:IDXX)
www.nasdaq.com - February 2 at 11:34 PM
finance.yahoo.com logoEdited Transcript of IDXX earnings conference call or presentation 2-Feb-17 1:30pm GMT (NASDAQ:IDXX)
finance.yahoo.com - February 2 at 11:34 PM
bloomberg.com logoRecent IDXX News (NASDAQ:IDXX)
www.bloomberg.com - February 2 at 6:33 PM
us.rd.yahoo.com logoIDEXX Laboratories Announces Fourth Quarter and Full Year 2016 Results (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
biz.yahoo.com logoQ4 2016 IDEXX Laboratories Inc Earnings Release - Before Market Open (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
us.rd.yahoo.com logo7:08 am IDEXX Labs beats by $0.07, beats on revs; guides FY17 EPS above consensus, reaffirms FY17 revs guidance (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
sg.finance.yahoo.com logoIdexx tops Street 4Q forecasts (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
us.rd.yahoo.com logoIDEXX Laboratories (IDXX) Beats Q4 Revenues, Y/Y EPS rises (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
us.rd.yahoo.com logoCramer's Stop Trading: IDXX (NASDAQ:IDXX)
us.rd.yahoo.com - February 2 at 6:33 PM
thestreet.com logoJim Cramer -- Idexx Labs Isn't Done Rallying (NASDAQ:IDXX)
www.thestreet.com - February 2 at 6:33 PM
fool.com logoWhy IDEXX Laboratories, Inc. Jumped Higher Today (NASDAQ:IDXX)
www.fool.com - February 2 at 6:33 PM
investors.com logoIdexx Lingers In Buy Zone Ahead Of Likely 'Good Quarter': Canaccord (NASDAQ:IDXX)
www.investors.com - February 1 at 6:36 PM
News IconAmerican Capital Management INC Stake in Idexx Laboratories (IDXX) Decreased by $7.87 Million as Stock Price Rose (NASDAQ:IDXX)
randolphguide.com - January 27 at 7:47 PM
News IconInstitutions Holding Steady in Their Positions of IDEXX Laboratories ... - Wall Street Beacon (NASDAQ:IDXX)
wsbeacon.com - January 26 at 5:18 AM
News IconUpdate on IDEXX Laboratories, Inc. (NASDAQ:IDXX) for the day (NASDAQ:IDXX)
twincountynews.com - January 25 at 7:16 PM
capitalcube.com logoIDEXX Laboratories, Inc. – Value Analysis (NASDAQ:IDXX) : January 25, 2017 (NASDAQ:IDXX)
www.capitalcube.com - January 25 at 7:16 PM
News IconSell-side is Weighing in on IDEXX Laboratories, Inc. (NASDAQ:IDXX) Earnings & Targets - Aiken Advocate (NASDAQ:IDXX)
aikenadvocate.com - January 25 at 4:36 AM
News IconIdexx Labs INC (IDXX) Holder Bamco INC Has Cut Position (NASDAQ:IDXX)
randolphguide.com - January 24 at 6:36 PM
capitalcube.com logoIDEXX Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : IDXX-US : January 24, 2017 (NASDAQ:IDXX)
www.capitalcube.com - January 24 at 6:36 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Wall Street Beacon (NASDAQ:IDXX)
wsbeacon.com - January 22 at 5:43 PM
benzinga.com logoJim Cramer Shares His Thoughts On IDEXX Laboratories, Express Scripts And Hanesbrands - Benzinga (NASDAQ:IDXX)
www.benzinga.com - January 20 at 3:19 PM
finance.yahoo.com logoIDEXX Laboratories (IDXX) Q4 Earnings: What's in Store? (NASDAQ:IDXX)
finance.yahoo.com - January 19 at 7:38 PM
finance.yahoo.com logoIDEXX Laboratories to Release 2016 Fourth Quarter and Full-Year Financial Results (NASDAQ:IDXX)
finance.yahoo.com - January 18 at 6:21 PM
thestreet.com logoAmazon, Merck, Freshpet: Jim Cramer's Views (NASDAQ:IDXX)
www.thestreet.com - January 16 at 8:55 AM
nasdaq.com logoCommit To Buy Idexx Laboratories At $100, Earn 4% Annualized Using Options (NASDAQ:IDXX)
www.nasdaq.com - January 14 at 5:09 AM
realistinvestor.com logoQuarterly Deferred Tax Assets Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) At $39.829 Millions - RealistInvestor.com (NASDAQ:IDXX)
www.realistinvestor.com - January 14 at 12:07 AM
News IconWill The Needle Move For IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:IDXX)
wsbeacon.com - January 13 at 7:06 PM
realistinvestor.com logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Mean Rating At $2.25 - RealistInvestor.com (NASDAQ:IDXX)
www.realistinvestor.com - January 9 at 6:32 PM

Social

What is IDEXX Laboratories' stock symbol?

IDEXX Laboratories trades on the NASDAQ under the ticker symbol "IDXX."

Where is IDEXX Laboratories' stock going? Where will IDEXX Laboratories' stock price be in 2017?

7 brokers have issued 1-year price objectives for IDEXX Laboratories' stock. Their forecasts range from $85.00 to $145.00. On average, they expect IDEXX Laboratories' share price to reach $118.33 in the next year.

When will IDEXX Laboratories announce their earnings?

IDEXX Laboratories is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.

Who owns IDEXX Laboratories stock?

IDEXX Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (3.15%), Atlanta Capital Management Co. L L C (2.49%), Federated Investors Inc. PA (1.09%), William Blair Investment Management LLC (0.80%), Brown Advisory Inc. (0.78%) and Renaissance Technologies LLC (0.69%). Company insiders that own IDEXX Laboratories stock include Barry C Johnson, Brian P Mckeon, Daniel M Junius, Johnny D Powers, Jonathan W Ayers, Michael J Phd Williams, Rebecca M Henderson, Thomas Craig and William T End.

Who sold IDEXX Laboratories stock? Who is selling IDEXX Laboratories stock?

IDEXX Laboratories' stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Federated Investors Inc. PA, FMR LLC, Royce & Associates LP, Two Sigma Investments LP, Baird Financial Group Inc., Renaissance Technologies LLC and Ruane Cunniff & Goldfarb Inc.. Company insiders that have sold IDEXX Laboratories stock in the last year include Barry C Johnson, Brian P Mckeon, Daniel M Junius, Jonathan W Ayers, Michael J Phd Williams, Rebecca M Henderson, Thomas Craig and William T End.

Who bought IDEXX Laboratories stock? Who is buying IDEXX Laboratories stock?

IDEXX Laboratories' stock was purchased by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Asset Management One Co. Ltd., Russell Investments Group Ltd., Guggenheim Capital LLC, Allianz Asset Management AG, AQR Capital Management LLC, Headinvest LLC and Turner Investments LLC.

How do I buy IDEXX Laboratories stock?

Shares of IDEXX Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of IDEXX Laboratories stock cost?

One share of IDEXX Laboratories stock can currently be purchased for approximately $142.23.

IDEXX Laboratories (NASDAQ:IDXX) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Earnings History Chart

Earnings by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Dividend History Chart

Dividend Payments by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Last Updated on 2/21/2017 by MarketBeat.com Staff